⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3573703 | 0.62 | — | — | |
| SCHEMBL17048816 | 0.57 | — | — | |
| SCHEMBL1442056 | 0.57 | — | — | |
| SCHEMBL8694778 | 0.56 | — | — | |
| SCHEMBL9778099 | 0.55 | — | — | |
| SCHEMBL9808495 | 0.53 | — | — | |
| SCHEMBL12764019 | 0.51 | — | — | |
| SCHEMBL155313 | 0.48 | — | — | |
| SCHEMBL3470529 | 0.48 | — | — | |
| SCHEMBL7086182 | 0.48 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365580-A1 | COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS | NOVARTIS AG (CH) | 2023-11-16 | — | — | US | disclosed |
| US-11753416-B2 | Compounds and compositions for inducing chondrogenesis | NOVARTIS AG (CH) | 2023-09-12 | — | — | US | disclosed |
| US-20210347784-A1 | COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS | NOVARTIS AG (CH) | 2021-11-11 | — | — | US | disclosed |
| US-11091499-B2 | Compounds and compositions for inducing chondrogenesis | NOVARTIS AG (CH) | 2021-08-17 | — | — | US | disclosed |
| US-20210079010-A1 | COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS | NOVARTIS AG (CH) | 2021-03-18 | — | — | US | disclosed |
| US-10787576-B2 | Method for the preparation of a coating comprising oligomeric alkynes | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2020-09-29 | — | — | US | disclosed |
| EP-3599239-A1 | METAL ORGANIC FRAMEWORKS AND METHODS FOR USING THEREOF | Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO (CH) | 2020-01-29 | — | — | EP | disclosed |
| US-20190048202-A1 | METHOD FOR THE PREPARATION OF A COATING COMPRISING OLIGOMERIC ALKYNES | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2019-02-14 | — | — | US | disclosed |
| US-20180171152-A1 | METHOD FOR THE PREPARATION OF A COATING | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2018-06-21 | — | — | US | disclosed |
| EP-3303482-A1 | METHOD FOR THE PREPARATION OF A COATING | Ecole Polytechnique Fédérale de Lausanne (EPFL) EPFL-TTO (CH) | 2018-04-11 | — | — | EP | disclosed |
| EP-1001946-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999067192-A2 | PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDE, KETONE, OXIME, AMINE, HYDROXAMIC ACID AND α,β-UNSATURATED CARBOXYLIC ACID AND ALDEHYDE COMPOUNDS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999038844-A1 | METHOD FOR PREPARING AN N-[(ALIPHATIC OR AROMATIC)CARBONYL]-2-AMINOACETAMIDE COMPOUND AND A CYCLYZED COMPOUND | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-08-05 | — | — | WO | disclosed |
| WO-1999031491-A1 | METHOD AND REAGENTS FOR THE QUANTIFICATION OF SOLID-PHASE REACTIONS USING FLUORINE NMR | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999025752-A1 | FUNCTIONALIZED RESIN FOR THE SYNTHESIS OF AMIDES AND PEPTIDES | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-05-27 | — | — | WO | disclosed |
| WO-1998054158-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES | RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| WO-1998054157-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES | RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| EP-0667857-A1 | INDOLYLCARBAMATES AS ANTI-INFLAMMATORY AGENTS | PFIZER INC. (US) | 1995-08-23 | — | — | EP | disclosed |
| WO-1994010144-A1 | INDOLYLCARBAMATES AS ANTI-INFLAMMATORY AGENTS | PFIZER INC. (US) | 1994-05-11 | — | — | WO | disclosed |
| US-5280039-A | Bicyclic carbamates and methods of treating inflammatory diseases using the same | PFIZER INC. (US) | 1994-01-18 | — | — | US | disclosed |